Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3

Aquestive Therapeutics Inc. (NASDAQ:AQST) is 1 of the 7 champion small-cap cause manufacturing stocks to bargain according to hedge funds.

On March 5, Alliance Global reduced the firm’s terms people connected Aquestive Therapeutics Inc. (NASDAQ:AQST) from $12 to $9. The steadfast maintained its Buy standing connected the shares. The determination follows the company’s 4th fourth net call, with the steadfast highlighting the planned NDA resubmission for Anaphylm successful 4th 3 2026 aft receiving a Complete Response Letter from the FDA.

Copyright: nexusplexus / 123RF Stock Photo

Alliance Global besides outlined a elaborate valuation crossed the company’s pipeline and assets, including contributions from Anaphylm, Libervant, and its basal business, supporting its updated presumption connected the shares.

On March 5, Aquestive Therapeutics Inc. (NASDAQ:AQST) announced its gross for the 4th fourth of $13.02 million, which was little than the statement estimates of $13.28 million. According to President and CEO Daniel Barber, Aquestive is well-positioned to beforehand Anaphylm, the archetypal and lone oral epinephrine rescue medication, toward FDA support for patients worldwide successful 2026.

The institution is focused connected rapidly addressing the human-focused deficiencies identified by the FDA successful its caller Complete Response Letter. The commercialized infrastructure is intact and transferable to the caller timeline arsenic the allergy marketplace continues to grow, and the diligent penchant for the innovation that Anaphylm brings to the allergy assemblage remains strong.

Aquestive Therapeutics Inc. (NASDAQ:AQST) works arsenic a pharmaceutical institution some successful the US and astir the world. It offers a wide scope of products, which see Libervant, Suboxone, EMYLIF, ONDIF, SYMPAZAN, KYNMOBI, and AZSTARYS. Anaphylm and AQST-108 are its proprietary pipeline items. Additionally, it has besides created Adrenaverse and PharmFilm technology.

While we admit the imaginable of AQST arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.